ristocetin and Hemolysis

ristocetin has been researched along with Hemolysis* in 1 studies

Other Studies

1 other study(ies) available for ristocetin and Hemolysis

Article	Year
[A conjugate of ristomycin A ristosaminylaglycon-polymyxin B: the spectrum of its antimicrobial action and its membranolytic activity]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1997, Volume: 42, Issue:5 Antimicrobial activity of a conjugate based on two antibiotics, i.e. ristomycin A and polymyxin B was studied. The conjugate was shown to have a broad antimicrobial spectrum. In concentrations of 5 to 30 micrograms/ml it inhibited the growth of gram-positive and gram-negative bacteria and in concentrations of 5 to 40 micrograms/ml it inhibited the growth of the pathogenic clinical strains. An insignificant membranolytic action of the conjugate with respect to membranes of the susceptible bacteria and no hemolytic action on human red blood cells were detected. Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemolysis; Humans; Microbial Sensitivity Tests; Polymyxin B; Protoplasts; Ristocetin	1997

Article

Year

[A conjugate of ristomycin A ristosaminylaglycon-polymyxin B: the spectrum of its antimicrobial action and its membranolytic activity].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1997, Volume: 42, Issue:5

Antimicrobial activity of a conjugate based on two antibiotics, i.e. ristomycin A and polymyxin B was studied. The conjugate was shown to have a broad antimicrobial spectrum. In concentrations of 5 to 30 micrograms/ml it inhibited the growth of gram-positive and gram-negative bacteria and in concentrations of 5 to 40 micrograms/ml it inhibited the growth of the pathogenic clinical strains. An insignificant membranolytic action of the conjugate with respect to membranes of the susceptible bacteria and no hemolytic action on human red blood cells were detected.

Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemolysis; Humans; Microbial Sensitivity Tests; Polymyxin B; Protoplasts; Ristocetin

1997